- IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
- IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
- IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
- IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
- IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
- IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
- IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
- IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
More ▼
Key statistics
On Monday, IRadimed Corp (IRMD:NMQ) closed at 42.82, 18.55% above the 52 week low of 36.12 set on Oct 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 43.07 |
---|---|
High | 43.29 |
Low | 42.60 |
Bid | 42.51 |
Offer | 43.19 |
Previous close | 42.90 |
Average volume | 50.52k |
---|---|
Shares outstanding | 12.66m |
Free float | 7.97m |
P/E (TTM) | 30.49 |
Market cap | 543.29m USD |
EPS (TTM) | 1.41 USD |
Annual div (ADY) | 0.600 USD |
---|---|
Annual div yield (ADY) | 1.40% |
Div ex-date | May 17 2024 |
Div pay-date | May 30 2024 |
Data delayed at least 15 minutes, as of Jun 24 2024 21:00 BST.
More ▼